Characterization of Patients with Ankylosing Spondylitis Receiving Secukinumab and Reasons for Initiating Treatment: A US Physician Survey and Retrospective Medical Chart Review

OBJECTIVES: To characterize US patients with ankylosing spondylitis (AS) who were treated with secukinumab and to assess rheumatologist-reported reasons for prescribing treatment in clinical practice. METHODS: This descriptive analysis of data from a US retrospective medical chart review included pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Joshi, Reeti, Latremouille-Viau, Dominick, Meiselbach, Mark K., Xie, Jipan, Park, Yujin, Sunkureddi, Prashanth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423254/
https://www.ncbi.nlm.nih.gov/pubmed/30617811
http://dx.doi.org/10.1007/s40801-018-0146-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6423254/
https://www.ncbi.nlm.nih.gov/pubmed/30617811
http://dx.doi.org/10.1007/s40801-018-0146-9

Ejemplares similares